what have changed?, page-12

Tend to agree with you Geezer, particularly as the market overall is down a fair bit. PRR is a standout today even though it has eased from todays highs. There has been nearly 34million shares so far at an average price of 22.6c. This sustained trend should uplift resistance levels. Naturally some people will take profits that can cause an easing of sp but I am impressed with the fact that their are sellers who are taking profits and yet the overall average trend is up. Interest in the stock seems to be building and if Nasdaq listing is approved I would be hoping that a lot of American money starts getting poured into this stock. Spreading the stock over two exchanges can only be a good thing IMO particularly as the USA is the place to be for biotechs. The comparisons with Dendreon can only help this company.

cheers